Type 2 Diabetes Patients With Long-Standing Disease Achieved Glycemic Control When BYETTA(R) Was Added To Lantus(R)
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) announced results from the first double-blind, placebo-controlled clinical study to evaluate BYETTA® (exenatide) injection added to Lantus® (insulin glargine), which showed patients with type 2 diabetes achieved glucose [...]
Tags : Achieved, Added, BYETTAR, Control, diabetes, disease, glycemic, LantusR, LongStanding, patients, type
1 in 5 or over 73.3 million North Americans are at risk for health issues caused by poor blood glucose control. The standard treatments are not working. The webmaster of www.Diabetic-Diet-Secrets.com wants to share what will work for most type 2 diabetics
Duration : 0:5:55
addthis_url = ‘http%3A%2F%2Fdiabetes-type-1.org%2Fdiabetes-type-2%2Fcontrolling-type-2-diabetes-with-diet’;
addthis_title [...]
Tags : blood, Diabetic, diet, Glucose, glycemic, low, software
